Funders › PA › Nf2 Biosolutions › 2024
Grants paid by Nf2 Biosolutions, tax year 2024
EIN 83-0940046 · West Chester, PA · Form 990, Schedule I · NTEE G20
In tax year 2024, Nf2 Biosolutions (EIN 83-0940046) reported 4 grants paid totaling $162,522. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Research Institute at Nationwide Ch Columbus, OH | A | $60,380 | paid | RESEARCH | 202543219349322319 |
| 2024 | Mass Gen Development Office Boston, MA | A | $60,000 | paid | DEVELOPMENT OF BACTERIOTHERAPY FOR NF2 | 202543219349322319 |
| 2024 | Yale University New Haven, CT | A | $36,351 | paid | TUMOR IMAGING MODEL | 202543219349322319 |
| 2024 | Merlin Therapeutics King of Prussia, PA | U | $5,791 | paid | RESEARCH | 202543219349322319 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.